[ad_1]
The European Union’s drug regulator said it would decide within weeks whether to approve the Pfizer pill for use against the coronavirus.
The United States has already authorized the use of the pill of the American pharmaceutical giant, Pfizer.
In December, the European Medicines Agency (EMA) empowered states to decide whether they wanted to issue an urgent approval for the use of the pill, known as Paxlovid.
But the EMA said it would now begin evaluating the pill in order to give it full approval for use in the 27 bloc countries.
“The EMA will assess the benefits and risks of Paxlovid in a short period of time and may publish the decision within weeks,” the agency said in a statement.
The EMA said the decision would depend on whether Pfizer’s data were “strong enough”.
This agency is also evaluating the application for approval of the pill created by the Merck company.
The US approved pills from Pfizer and Merck in December.
Both pills are said to contribute to the fight against COVID-19 disease, as studies have shown that they reduce the risk of hospitalizations and deaths among patients considered to be at high risk for coronavirus.
top channel
[ad_2]
Source link
